🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This open-label study will evaluate EMB-001, comprised of metyrapone, a cor...
Status
Unknown
Location
Rose Research Center
Start Date
2021-05-19
Trial ID
NCT04868253
Treatments Being Tested
This is a study of EMB-001 (a combination of two FDA-approved drugs, metyra...
Status
Completed
Location
Collaborative Neuroscience Network, LLC
Start Date
2018-03-01
Trial ID
NCT03404817
Treatments Being Tested
EMB-001 is a combination of 2 drugs: the cortisol synthesis inhibitor, mety...
Status
Completed
Location
Pacific Treatment and Research Center, Department of Psychiatry, University of California, San Diego, School of Medicine
Start Date
2020-07-29
Trial ID
NCT04501874
Treatments Being Tested
EMB-001 is a combination of 2 drugs: the cortisol synthesis inhibitor, mety...
Status
Terminated
Location
Embera Site
Start Date
2021-06-10
Trial ID
NCT04933916
Treatments Being Tested
EMB-001 is a combination of 2 drugs: the cortisol synthesis inhibitor, mety...
Status
Completed
Location
Vince & Associates
Start Date
2016-07
Trial ID
NCT02856854
Treatments Being Tested
This is a study of EMB-001 (a combination of two FDA-approved drugs, metyra...
Status
Completed
Location
Collaborative Neuroscience Network, LLC
Start Date
2015-03
Trial ID
NCT02406066
Treatments Being Tested